|
EP2155787A4
(en)
|
2007-05-11 |
2010-06-16 |
Temasek Life Sciences Lab Ltd |
SPECIFIC TO THE H5-SUBTYPE BINDING PROTEINS SUITED TO THE DIAGNOSIS AND MONITORING OF THE H5 BIRGRAP
|
|
AU2016202118B2
(en)
*
|
2009-03-20 |
2017-10-26 |
Amgen Inc. |
Carrier immunoglobulins and uses thereof
|
|
US8771693B2
(en)
|
2009-10-27 |
2014-07-08 |
Beth Israel Deaconess Medical Center, Inc. |
Methods and compositions for the generation and use of conformation-specific antibodies
|
|
CN103702967A
(zh)
|
2011-03-14 |
2014-04-02 |
貝丝以色列女执事医疗中心 |
用于治疗增殖性病症的方法和组合物
|
|
WO2012149334A2
(en)
|
2011-04-27 |
2012-11-01 |
Beth Israel Deaconess Medical Center, Inc. |
Methods and compositions for the generation and use of conformation-specific antibodies
|
|
WO2012162698A1
(en)
|
2011-05-26 |
2012-11-29 |
Beth Israel Deaconess Medical Center, Inc. |
Methods and compositions for the treatment of immune disorders
|
|
EP2739587B1
(en)
|
2011-08-01 |
2020-05-27 |
Denovo Sciences |
Cell capture system
|
|
US10466160B2
(en)
|
2011-08-01 |
2019-11-05 |
Celsee Diagnostics, Inc. |
System and method for retrieving and analyzing particles
|
|
US9730941B2
(en)
|
2012-06-07 |
2017-08-15 |
Beth Israel Deaconess Medical Center, Inc. |
Methods and compositions for the inhibition of Pin1
|
|
UY35148A
(es)
|
2012-11-21 |
2014-05-30 |
Amgen Inc |
Immunoglobulinas heterodiméricas
|
|
AU2014240063B2
(en)
|
2013-03-15 |
2019-04-11 |
Beth Israel Deaconess Medical Center, Inc. |
Methods and compositions for the generation and use of conformation-specific antibodies
|
|
WO2014144817A2
(en)
|
2013-03-15 |
2014-09-18 |
Amgen Inc. |
Inhibitory polypeptides specific to wnt inhibitors
|
|
US10391490B2
(en)
|
2013-05-31 |
2019-08-27 |
Celsee Diagnostics, Inc. |
System and method for isolating and analyzing cells
|
|
WO2015035215A1
(en)
|
2013-09-05 |
2015-03-12 |
Amgen Inc. |
Fc-containing molecules exhibiting predictable, consistent, and reproducible glycoform profiles
|
|
AU2015259053B2
(en)
|
2014-05-16 |
2020-12-24 |
Amgen Inc. |
Assay for detecting Th1 and Th2 cell populations
|
|
US9968579B2
(en)
|
2014-07-17 |
2018-05-15 |
Beth Isreal Deaconess Medical Center, Inc. |
ATRA for modulating Pin1 activity and stability
|
|
WO2016011265A2
(en)
|
2014-07-17 |
2016-01-21 |
Beth Israel Deaconess Medical Center, Inc. |
Biomarkers for pin1-associated disorders
|
|
US10548864B2
(en)
|
2015-03-12 |
2020-02-04 |
Beth Israel Deaconess Medical Center, Inc. |
Enhanced ATRA-related compounds for the treatment of proliferative diseases, autoimmune diseases, and addiction conditions
|
|
US20190284259A1
(en)
*
|
2016-07-22 |
2019-09-19 |
Georgia State University Research Foundation |
Monoclonal Antibodies to B Virus And Their Use For Identification Of B Virus Specific Reactive Peptides
|
|
JP7672196B2
(ja)
|
2017-03-14 |
2025-05-07 |
アムジエン・インコーポレーテツド |
細胞培養において産生される抗体の総非フコシル化グリコフォームの調節
|
|
AU2018323449B2
(en)
|
2017-08-29 |
2020-09-03 |
Bio-Rad Laboratories, Inc. |
System and method for isolating and analyzing cells
|
|
EP3775251A1
(en)
|
2018-03-26 |
2021-02-17 |
Amgen Inc. |
Total afucosylated glycoforms of antibodies produced in cell culture
|
|
USD903413S1
(en)
|
2018-08-09 |
2020-12-01 |
Sharkninja Operating Llc |
Cooking basket
|
|
CN118546959A
(zh)
|
2019-03-05 |
2024-08-27 |
恩卡尔塔公司 |
Cd19定向性嵌合抗原受体及其在免疫疗法中的用途
|
|
US10633693B1
(en)
|
2019-04-16 |
2020-04-28 |
Celsee Diagnostics, Inc. |
System and method for leakage control in a particle capture system
|
|
US11339190B2
(en)
*
|
2020-04-21 |
2022-05-24 |
Rush University Medical Center |
Peptides for the treatment of covid-19
|
|
SG11202112151UA
(en)
|
2019-05-07 |
2021-12-30 |
Bio Rad Laboratories |
System and method for automated single cell processing
|
|
US11273439B2
(en)
|
2019-05-07 |
2022-03-15 |
Bio-Rad Laboratories, Inc. |
System and method for target material retrieval from microwells
|
|
KR20250084977A
(ko)
*
|
2019-06-14 |
2025-06-11 |
바이오 래드 래버러토리스 인코오포레이티드 |
자동화된 단일 세포 처리 및 분석을 위한 시스템 및 방법
|
|
CA3152547A1
(en)
|
2019-09-26 |
2021-04-01 |
Amgen Inc. |
Methods of producing antibody compositions
|
|
AU2021222039A1
(en)
*
|
2020-02-19 |
2022-09-29 |
United Biomedical, Inc. |
Designer peptides and proteins for the detection, prevention and treatment of Coronavirus Disease, 2019 (COVID-19)
|
|
HRP20231031T1
(hr)
|
2020-02-26 |
2023-12-22 |
Vir Biotechnology, Inc. |
Protutijela protiv sars-cov-2
|
|
CN112500498B
(zh)
*
|
2020-02-26 |
2022-09-06 |
四川大学 |
新型冠状病毒疫苗及其制备方法和应用
|
|
WO2021190980A1
(en)
*
|
2020-03-22 |
2021-09-30 |
Quadrucept Bio Limited |
Multimers for viral strain evolution
|
|
EP4126933A1
(en)
*
|
2020-03-22 |
2023-02-08 |
Quadrucept Bio Limited |
Multimers for viral strain evolution
|
|
CN113429476A
(zh)
*
|
2020-03-23 |
2021-09-24 |
泰州迈博太科药业有限公司 |
一种结合冠状病毒的双功能融合蛋白、其制备方法及应用
|
|
CN115279785B
(zh)
*
|
2020-03-25 |
2025-09-05 |
神州细胞工程有限公司 |
SARS-CoV-2和SARS-CoV交叉中和抗体的制备及应用
|
|
WO2021198220A1
(en)
*
|
2020-03-30 |
2021-10-07 |
Allero Therapeutics B.V. |
Treatment and prevention of secondary inflammation in patients suffering from a viral infection
|
|
WO2021201679A1
(en)
|
2020-04-01 |
2021-10-07 |
Kiadis Pharma Intellectual Property B.V. |
Compositions and methods targeting coronaviruses
|
|
US20230106770A1
(en)
*
|
2020-04-06 |
2023-04-06 |
Phylex Biosciences, Inc. |
Reagents and methods for preventing, treating or limiting severe acute respiratory syndrome (SARS) coronavirus infection
|
|
MX2022012685A
(es)
|
2020-04-10 |
2023-03-08 |
Invivyd Inc |
Compuestos específicos contra la proteína s de coronavirus y usos de los mismos.
|
|
WO2021214467A1
(en)
*
|
2020-04-23 |
2021-10-28 |
Cellbio |
A diagnostic tool improvement comprising a pathogen binding molecule
|
|
US20230399384A1
(en)
*
|
2020-04-24 |
2023-12-14 |
The Board Of Regents Of The University Of Texas System |
Antibodies to coronavirus spike protein and methods of use thereof
|
|
CN115916256A
(zh)
*
|
2020-04-24 |
2023-04-04 |
单细胞科技公司 |
抗sars冠状病毒2型刺突蛋白抗体
|
|
KR102351653B1
(ko)
*
|
2020-04-29 |
2022-01-14 |
한국화학연구원 |
사스 코로나바이러스 2 스파이크 단백질과 결합하는 수용체와 항체를 포함하는 사스 코로나바이러스 2 진단 키트
|
|
US20230160895A1
(en)
*
|
2020-04-29 |
2023-05-25 |
Korea Research Institute Of Chemical Technology |
Sars coronavirus 2 diagnostic kit including receptor and antibody binding to sars coronavirus 2 spike protein
|
|
WO2021221668A1
(en)
*
|
2020-04-30 |
2021-11-04 |
iRepertoire, Inc. |
Anti-sars-cov-2 monoclonal antibody compositions
|
|
US20230168249A1
(en)
*
|
2020-05-06 |
2023-06-01 |
Academia Sinica |
Recombinant antibodies, kits comprising the same, and uses thereof
|
|
CN113667010B
(zh)
*
|
2020-05-15 |
2023-07-28 |
普米斯生物技术(珠海)有限公司 |
冠状病毒的抗体及其衍生物用途
|
|
WO2021237051A1
(en)
*
|
2020-05-22 |
2021-11-25 |
Jecho Laboratories, Inc. |
SARS-CoV-2 ANTIBODY AND RELATED METHODS
|
|
WO2021238910A1
(en)
*
|
2020-05-25 |
2021-12-02 |
Guo Bingshi |
Anti-coronavirus spike protein antibodies and uses thereof
|
|
US20230273126A1
(en)
|
2020-06-04 |
2023-08-31 |
Amgen Inc. |
Assessment of cleaning procedures of a biotherapeutic manufacturing process
|
|
IL298510A
(en)
*
|
2020-06-12 |
2023-01-01 |
Nkarta Inc |
Genetically modified natural killer cells for cd70-directed cancer immunotherapy
|
|
WO2021257695A2
(en)
*
|
2020-06-16 |
2021-12-23 |
Hifibio (Hk) Limited |
Methods and compositions related to neutralizing antibodies against human coronavirus
|
|
KR102662789B1
(ko)
*
|
2020-07-01 |
2024-05-03 |
앱클론(주) |
항-SARS-CoV-2 S 단백질 항체 또는 그의 항원 결합 단편, 및 이를 포함하는 SARS-CoV-2 감염증의 예방 또는 치료용 약제학적 조성물
|
|
CN113945714B
(zh)
*
|
2020-07-16 |
2023-01-31 |
南京蓬勃生物科技有限公司 |
新型冠状病毒中和抗体类药物中和能力的检测方法
|
|
MX2023000267A
(es)
*
|
2020-07-16 |
2023-02-13 |
Caregen Co Ltd |
Peptido con actividad neutralizante contra el coronavirus 2 del sindrome respiratorio agudo grave.
|
|
CN116693671A
(zh)
*
|
2020-07-20 |
2023-09-05 |
福建医科大学附属协和医院 |
新型冠状病毒中和性抗体及其制备方法与用途
|
|
CN113336831A
(zh)
*
|
2020-07-24 |
2021-09-03 |
上海延立药业有限公司 |
一种用于开发新冠病毒疫苗的长效重组糖蛋白
|
|
WO2022026775A1
(en)
*
|
2020-07-30 |
2022-02-03 |
Prellis Biologics, Inc |
Compositions and methods for targeting coronavirus
|
|
US11988671B2
(en)
*
|
2020-08-04 |
2024-05-21 |
Abbott Rapid Diagnostics International Unlimited Company |
Assays for detecting SARS-CoV-2
|
|
EP4206224A4
(en)
|
2020-08-26 |
2025-04-02 |
National University Corporation Kumamoto University |
Human antibody or antigen-binding fragment thereof against coronavirus spike protein
|
|
WO2022051223A1
(en)
*
|
2020-09-02 |
2022-03-10 |
The Feinstein Institutes For Medical Research |
Use of sars-cov-2 receptor binding motif (rbm)-reactive monoclonal antibodies to treat covid-19
|
|
CN114159445B
(zh)
*
|
2020-09-11 |
2024-03-19 |
中国科学院分子细胞科学卓越创新中心 |
筛选抑制新型冠状病毒感染的小分子药物的方法及其应用
|
|
WO2022054068A1
(en)
*
|
2020-09-14 |
2022-03-17 |
Ramot At Tel-Aviv University Ltd. |
Antibodies for the prevention, treatment and detection of coronavirus infection
|
|
EP3970798A1
(en)
*
|
2020-09-18 |
2022-03-23 |
NMI Naturwissenschaftliches und Medizinisches Institut an der Universität Tübingen |
Sars-cov-2-nanobodies
|
|
GB202015755D0
(en)
*
|
2020-10-05 |
2020-11-18 |
Rogers Arpi |
Coronavirus therapy
|
|
JP2023548767A
(ja)
|
2020-10-15 |
2023-11-21 |
アムジエン・インコーポレーテツド |
抗体製造方法における相対不対グリカン
|
|
KR102437114B1
(ko)
*
|
2020-10-21 |
2022-08-26 |
재단법인 바이오나노헬스가드연구단 |
스트렙트아비딘 결합 펩타이드가 태그된 중증급성호흡기증후군 코로나바이러스 특이적 항원 및 이의 용도
|
|
CN112442120A
(zh)
*
|
2020-11-25 |
2021-03-05 |
苏州大学 |
抗严重急性呼吸系统综合征ii型冠状病毒sars-cov-2的中和抗体
|
|
CN114605527B
(zh)
*
|
2020-12-04 |
2023-07-04 |
中国科学院分子细胞科学卓越创新中心 |
一种抗新型冠状病毒SARS-CoV-2的抗体及其制备方法和用途
|
|
CN115087667B
(zh)
*
|
2020-12-14 |
2023-06-23 |
杰科（天津）生物医药有限公司 |
特异性结合SARS-CoV-2的抗原结合蛋白
|
|
CN114716541B
(zh)
*
|
2021-01-05 |
2023-07-21 |
中国科学院分子细胞科学卓越创新中心 |
抗冠状病毒的全人广谱中和抗体76e1及其应用
|
|
TW202237642A
(zh)
*
|
2021-01-08 |
2022-10-01 |
美商１０Ｘ基因組學有限公司 |
對冠狀病毒具有特異性的抗原結合多肽及其用途
|
|
WO2022156670A1
(en)
*
|
2021-01-19 |
2022-07-28 |
Hifibio (Hk) Limited |
Multispecific antibodies against sars-cov-2 and methods of use thereof
|
|
WO2022159685A2
(en)
*
|
2021-01-22 |
2022-07-28 |
Vanderbilt University |
Sars-cov-2 coronavirus antibodies and uses thereof
|
|
JP7539479B2
(ja)
*
|
2021-02-10 |
2024-08-23 |
シーチュアン バイリ ファーマスーティカル シーオー． エルティーディー． |
組換えａｃｅ２－ｆｃ融合分子、その製造方法及びその使用
|
|
WO2022177870A1
(en)
*
|
2021-02-17 |
2022-08-25 |
The Board Of Regents Of The University Of Texas System |
Multimeric sars-cov-2 binding molecules and uses thereof
|
|
WO2022261021A1
(en)
|
2021-06-07 |
2022-12-15 |
Amgen Inc. |
Using fucosidase to control afucosylation level of glycosylated proteins
|
|
WO2023039064A2
(en)
*
|
2021-09-08 |
2023-03-16 |
The Scripps Research Institute |
Broadly neutralizing antibodies against sars-like viruses
|
|
CN113943375B
(zh)
*
|
2021-10-01 |
2022-08-16 |
中国科学院昆明动物研究所 |
一类来源于新型冠状病毒s2蛋白hr区域的重组融合蛋白及其应用
|
|
EP4413377A1
(en)
|
2021-10-05 |
2024-08-14 |
Amgen Inc. |
Fc-gamma receptor ii binding and glycan content
|
|
EP4466284A2
(en)
*
|
2021-10-27 |
2024-11-27 |
Twist Bioscience Corporation |
Multispecific sars-cov-2 antibodies and methods of use
|
|
CN118369438A
(zh)
|
2021-12-10 |
2024-07-19 |
伯乐实验室有限公司 |
用形态可调节功能化颗粒进行样品处理的组合物、方法和系统
|
|
WO2023215725A1
(en)
|
2022-05-02 |
2023-11-09 |
Fred Hutchinson Cancer Center |
Compositions and methods for cellular immunotherapy
|
|
CN115028715B
(zh)
*
|
2022-06-23 |
2023-08-18 |
生工生物工程（上海）股份有限公司 |
一种抗新型冠状病毒的抗体或其抗原结合片段、试剂盒及应用
|
|
AU2024256160A1
(en)
|
2023-04-20 |
2025-10-02 |
Amgen Inc. |
Methods of determining relative unpaired glycan content
|
|
WO2025038600A1
(en)
|
2023-08-14 |
2025-02-20 |
Amgen Inc. |
Methods for reducing yellow color
|
|
WO2025101820A1
(en)
|
2023-11-08 |
2025-05-15 |
Fred Hutchinson Cancer Center |
Compositions and methods for cellular immunotherapy
|